BioMark Diagnostics (20B) Ownership - Who Owns BioMark Diagnostics?
BioMark Diagnostics (20B) Ownership Overview
- 53.45% Insiders
- 46.55% Public Companies and Individual Investors
The ownership structure of BioMark Diagnostics (DE:20B) stock is a mix of institutional, retail, and individual investors. , 53.45% is owned by Insiders, and 46.55% is owned by Public Companies and Individual Investors.
The ownership structure of BioMark Diagnostics (DE:20B) stock is a mix of institutional, retail, and individual investors. , 53.45% is owned by Insiders, and 46.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 16, 2026 | Rashid Bux | C$6,195 | |
| Sep 11, 2026 | Rashid Bux | C$3,771 | |
| Aug 28, 2026 | Rashid Bux | C$2,804 | |
| Jul 17, 2026 | Guoyu Huang | C$5,600 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Rashid Bux | 46,230,331 | Insider | 43.42% | 13,730,408 |
| Guoyu Huang | 5,429,700 | Insider | 5.10% | 1,612,621 |
| James Arthur Lavender | 5,252,483 | Insider | 4.93% | 1,559,987 |
FAQ
What percentage of BioMark Diagnostics (DE:20B) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.55% of BioMark Diagnostics (DE:20B) stock is held by public companies and individual investors.
Who owns the most shares of BioMark Diagnostics (DE:20B)?
Rashid Bux owns the most shares of BioMark Diagnostics (DE:20B).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
